When fear takes control: the multidrug resistance story during pandemics.

In contrast, a European multi-centre study on the incidence of ventilator-associated lower respiratory tract infections suggested that MDRO was lower in the COVID-19 patients than in the non-COVID comparators [[5]]. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Patients who develop severe coronavirus disease 2019 (COVID-19) suffer nosocomial infections that were not only the commonest single category of complications, affecting over 50% of COVID-19 patients in intensive care unit (ICU) [[1]], but also sit at the intersection of two pandemics, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and antimicrobial resistance (AMR). However, studies examining COVID-19 and non-COVID-19 patients managed in the same unit under the same PPE conditions do not support local infection prevention and control (IPC) breaches as the dominant driver of MDRO transmission [[12]]. [Extracted from the article]